This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Realty Income (O) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Realty Income (O) will likely gain from focus on tenants from its service, non-discretionary and Internet-resilient business amid choppy retail real estate market in Q2.
Physicians Realty Trust (DOC) Lags Q1 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of -3.85% and 1.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Realty Completes MOB Buyouts in Potential Markets
by Zacks Equity Research
Healthcare Realty (HR) completes purchase of four properties, amid soaring popularity for medical-office buildings.
Healthcare Realty (HR) Prices Offering of 3.25M Common Stock
by Zacks Equity Research
Healthcare Realty's (HR) latest public offering of common stock will improve its financial flexibility and provide ample scope for deploying capital in accretive acquisitions.
Why Trending Outpatient Care is a Boon for Healthcare REITs
by Devyani Chamria
Amid shift of care to low-cost setting, medical office buildings (MOBs) and outpatient facilities have been creating opportunities for healthcare REITs to park their money.
Physicians Realty Trust (DOC) Tops Q3 FFO and Revenue Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 3.70% and 0.80%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for W. P. Carey (WPC) This Earnings Season?
by Zacks Equity Research
W. P. Carey's (WPC) Q3 results likely to benefit from the company's high-quality portfolio and strategic investments.
What's in Store for Brighthouse Financial (BHF) Q3 Earnings?
by Zacks Equity Research
Brighthouse Financial (BHF) Q3 is likely to be aided by compelling portfolio of life and annuity products coupled with its strong market presence.
Is a Surprise Coming for Physicians Realty Trust (DOC) This Earnings Season?
by Zacks Equity Research
Physicians Realty Trust (DOC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Physicians Realty Trust (DOC) Q2 Earnings Meet Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered earnings and revenue surprises of 0.00% and 2.52%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?